The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Astepro 1 mg/ml Nasal Spray, Solution

Meda Health Sales Ireland LimitedPA1332/039/001

Main Information

Trade NameAstepro 1 mg/ml Nasal Spray, Solution
Active SubstancesAzelastine hydrochloride
Dosage FormNasal spray, solution
Licence HolderMeda Health Sales Ireland Limited
Licence NumberPA1332/039/001

Group Information

ATC CodeR01AC Antiallergic agents, excl. corticosteroids
R01AC03 azelastine


License statusAuthorised
Licence Issued05/10/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back